Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Including known covariates can reduce power to detect genetic effects in case-control studies.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
Endogeneous Remyelination: Findings in Human Studies.
Simvastatin: a review.
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
Plasma chemerin levels in patients with multiple sclerosis.
[Epstein-Barr virus in the pathogenesis of multiple sclerosis (a review).]
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Axonal damage in acute multiple sclerosis lesions.
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Genetics of primary progressive multiple sclerosis.
Pregnancy in multiple sclerosis: a questionnaire study.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
Our history
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.

Pages